RxDoctor Payments Data

Rebecca Kelley

Adult Health · Glen Burnie, MDNPI 1679292007

Payments from drug & device makers

$1,429in general payments, 2019–2025

Across 40 payments — averaging $35.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$321
  • Enterra Medical, Inc.$310
  • Ardelyx, Inc.$161
  • QOL Medical, LLC$146
  • Sanofi-aventis U.S. LLC$93
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$72
  • plus $326 from 12 others

What the payments were for

  • Travel & lodging$715%
  • Food & beverage$1,35895%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,429 in reported general payments places this provider in the 75th percentile of 542 adult health providers in Maryland.

See all adult health providers in Maryland

Medicare billing

Part B allowed, 2024
$89,363
Medicare patients
323
Services billed
1,191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide18$22,060
EliquisApixaban32$17,753
MotegrityPrucalopride Succinate15$14,420
TrulancePlecanatide11$7,915
Lubiprostone23$5,847
Sucralfate25$2,115
Atorvastatin Calcium46$1,211
Tinidazole17$1,091
Famotidine50$999
Mirtazapine27$946
Dicyclomine Hcl23$930
Omeprazole54$911
Promethazine Hcl28$657
Amlodipine Besylate34$495
Pantoprazole Sodium19$460

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$321$22,06018 claims
PfizerEliquis$18$17,75332 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$72$7,91511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 542 adult health providers in Maryland.

Other adult health in Glen Burnie

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →